Cargando…
Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells
Pancreatic ductal adenocarcinoma (PDAC) is projected to become the second deadliest cancer by 2030, and the overall 5-year survival rate is currently less than 7%. Cancer cells frequently exhibit reprogramming of their metabolic activity. It is increasingly recognized that aberrant de novo lipid syn...
Autores principales: | Sunami, Yoshiaki, Rebelo, Artur, Kleeff, Jörg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789353/ https://www.ncbi.nlm.nih.gov/pubmed/29295482 http://dx.doi.org/10.3390/cancers10010003 |
Ejemplares similares
-
Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis
por: Bai, Rubing, et al.
Publicado: (2021) -
Lipid Droplet-Associated Factors, PNPLA3, TM6SF2, and HSD17B Proteins in Hepatopancreatobiliary Cancer
por: Sunami, Yoshiaki, et al.
Publicado: (2021) -
Cholesterol Metabolism in Pancreatic Cancer
por: Rebelo, Artur, et al.
Publicado: (2023) -
Cellular Heterogeneity of Pancreatic Stellate Cells, Mesenchymal Stem Cells, and Cancer-Associated Fibroblasts in Pancreatic Cancer
por: Sunami, Yoshiaki, et al.
Publicado: (2020) -
Targeting and Reprograming Cancer-Associated Fibroblasts and the Tumor Microenvironment in Pancreatic Cancer
por: Sunami, Yoshiaki, et al.
Publicado: (2021)